STANLEY CZAJKOWSKI: Open Payments
NPI 1902878507 · MECHANICSVILLE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,814 in 34 payments from 16 companies in 2025. Trend: 2023 $2,183 · 2024 $1,407 · 2025 $1,814
Food & beverage: $1,795Education: $19
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $250 |
| Otsuka America Pharmaceutical, Inc. | 2 | $246 |
| Inspire Medical Systems, Inc. | 2 | $178 |
| Amgen Inc. | 5 | $177 |
| GlaxoSmithKline, LLC. | 1 | $125 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $124 |
| Xeris Pharmaceuticals, Inc. | 1 | $122 |
| Axsome Therapeutics, Inc. | 1 | $121 |
| Lilly USA, LLC | 1 | $120 |
| Sumitomo Pharma America, Inc. | 1 | $115 |
Products named: REXULTI, QULIPTA, INSPIRE, REPATHA, AREXVY, Kerendia, GVOKE HYPOPEN, Auvelity.
Industry payments across VA — which companies pay providers there.
